NICE faces legal challenge over Alzheimer's drugBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39168.342523.DB (Published 29 March 2007) Cite this as: BMJ 2007;334:654
- Clare Dyer, legal correspondent
The National Institute for Health and Clinical Excellence (NICE), the NHS drugs gatekeeper for England and Wales, faces the first legal challenge to one of its decisions restricting the use of a drug by the NHS.
The High Court gave the go ahead this week to a drug company to bring judicial review proceedings over restrictions on the use of donepezil (Aricept), which is used to treat Alzheimer's disease.
Guidance from NICE, which does cost-benefit …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial